Skip to main content
Premium Trial:

Request an Annual Quote

CSHL Gets $1.3M to Manage Data for NHGRI's ModENCODE Project

NEW YORK (GenomeWeb News) - The National Human Genome Research Institute has awarded $1.3 million to Cold Spring Harbor Laboratory to coordinate the data that will come from its recently launched modEncode project, CSHL said Tuesday.
 
CSHR researcher Lincoln Stein will lead the data-coordination project.
 
On Monday, NHGRI said that it had awarded a total of $57 million to ten research facilities under the modENCODE project, which aims to identify functional elements in the genomes of the model organisms Drosophila melanogaster and Caenorhabditis elegans.
 
The data from the modENCODE initiative is expected to be useful for genomic studies for humans and other organisms.
 
The CSHL data-coordination center will collaborate with computer scientists in the UK and in California to integrate the genomic data into a centralized database and combine it with public information from other sources.
 
The information then will be publicly available online.
 

Stein said in a statement that the project will "open an unprecedented window to how the elements of the genome influence the development of roundworms and fruit flies and how they respond to the environment." 

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.